Published in Acta Paediatr Scand Suppl on January 01, 1970
The development of stability of respiration in human infants: changes in ventilatory responses to spontaneous sighs. J Physiol (1984) 1.10
Acute effects of instillation of surfactant in severe respiratory distress syndrome. Arch Dis Child (1989) 1.09
Monitoring for central apnoea in infancy--limitations of single channel recordings. Arch Dis Child (1988) 1.07
Stroke damage detection using classification trees on electrical bioimpedance cerebral spectroscopy measurements. Sensors (Basel) (2013) 0.83
Intracranial hemorrhage alters scalp potential distribution in bioimpedance cerebral monitoring: Preliminary results from FEM simulation on a realistic head model and human subjects. Med Phys (2016) 0.78
A physiologic approach to cord clamping: Clinical issues. Matern Health Neonatol Perinatol (2015) 0.75
Transient inhibition of histone deacetylation alters the structural and functional imprint at fission yeast centromeres. Cell (1997) 3.72
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol (2000) 2.99
Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol (1998) 2.97
Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. J Intern Med (2013) 2.74
Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab (2001) 2.33
Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy. Neurology (2011) 2.26
Replication of the association between variants in WFS1 and risk of type 2 diabetes in European populations. Diabetologia (2007) 2.23
Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J Clin Endocrinol Metab (2011) 2.16
Antibodies to MOG are transient in childhood acute disseminated encephalomyelitis. Neurology (2011) 2.07
HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol (2000) 2.05
Cancer risk among patients with multiple sclerosis and their parents. Neurology (2009) 2.03
Remaining sequelae with modern perinatal care. Pediatrics (1976) 1.69
Shared genetic factors may not explain the raised risk of comorbid inflammatory diseases in multiple sclerosis. Mult Scler (2012) 1.65
T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol (1991) 1.65
Hemiosteoporosis after severe stroke, independent of changes in body composition and weight. Stroke (1999) 1.63
Epidemiology and etiology of ischemic stroke in young adults aged 18 to 44 years in northern Sweden. Stroke (1997) 1.61
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations. J Med Genet (2008) 1.59
Differential susceptibilities of mice genomically deleted of CD4 and CD8 to infections with Trypanosoma cruzi or Trypanosoma brucei. Infect Immun (1993) 1.59
Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology (2009) 1.59
Blunted adrenocorticotropin and increased adrenal steroid response to human corticotropin-releasing hormone in Alzheimer's disease. Biol Psychiatry (1996) 1.56
Leptin is associated with increased risk of myocardial infarction. J Intern Med (1999) 1.52
Fractures after stroke. Osteoporos Int (1998) 1.47
Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci (2000) 1.44
Detection of intracellular expression and secretion of interferon-gamma at the single-cell level after activation of human T cells with tetanus toxoid in vitro. Eur J Immunol (1990) 1.42
Maternal smoking during pregnancy and multiple sclerosis amongst offspring. Eur J Neurol (2008) 1.41
[Cervical manipulation--is it really justifiable?]. Lakartidningen (1992) 1.39
Bronchostenosis due to sarcoidosis: a cause of atelectasis and airway obstruction simulating pulmonary neoplasm and chronic obstructive pulmonary disease. Chest (1979) 1.39
Impaired incretin response after a mixed meal is associated with insulin resistance in nondiabetic men. Diabetes Care (2001) 1.38
Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit. Proc Natl Acad Sci U S A (1996) 1.38
A population-based study of coeliac disease, neurodegenerative and neuroinflammatory diseases. Aliment Pharmacol Ther (2007) 1.37
Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci U S A (1989) 1.36
Screening of several H-2 congenic mouse strains identified H-2(q) mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. J Neuroimmunol (2000) 1.36
Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol (1991) 1.36
A low dose ACTH test to assess the function of the hypothalamic-pituitary-adrenal axis. Clin Endocrinol (Oxf) (1996) 1.36
Intracranial hemorrhage in the prematurely born infant. Timing of clots and evaluation of clinical signs and symptoms. J Pediatr (1974) 1.33
Increased transforming growth factor-beta, interleukin-4, and interferon-gamma in multiple sclerosis. Ann Neurol (1994) 1.33
MHC haplotype-dependent regulation of MOG-induced EAE in rats. J Clin Invest (1998) 1.33
Estrogen induces a potent suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis in mice. J Neuroimmunol (1994) 1.31
Leptin, but not adiponectin, predicts stroke in males. J Intern Med (2004) 1.31
Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. J Intern Med (2000) 1.29
Two genes encoding immune-regulatory molecules (LAG3 and IL7R) confer susceptibility to multiple sclerosis. Genes Immun (2005) 1.28
Regulation of telomere length by checkpoint genes in Schizosaccharomyces pombe. Mol Biol Cell (1998) 1.27
Leptin is associated with increased prostate cancer risk: a nested case-referent study. J Clin Endocrinol Metab (2001) 1.20
In vivo treatment of rats with monoclonal anti-T-cell antibodies. Immunohistochemical and functional analysis in normal rats and in experimental allergic neuritis. Scand J Immunol (1985) 1.20
Protracted, relapsing and demyelinating experimental autoimmune encephalomyelitis in DA rats immunized with syngeneic spinal cord and incomplete Freund's adjuvant. J Neuroimmunol (1995) 1.19
Depletion of CD8+ T cells suppresses growth of Trypanosoma brucei brucei and interferon-gamma) production in infected rats. Clin Exp Immunol (1990) 1.17
Epstein-Barr virus and multiple sclerosis: interaction with HLA. Genes Immun (2011) 1.17
Suppression of experimental autoimmune myasthenia gravis by nasal administration of acetylcholine receptor. J Neuroimmunol (1995) 1.17
Expression of MHC class I and beta2-microglobulin in rat spinal motoneurons: regulatory influences by IFN-gamma and axotomy. Exp Neurol (1998) 1.17
Histochemical detection of 4-hydroxynonenal protein in Alzheimer amyloid. J Neurol Sci (1998) 1.16
Increased levels of proinflammatory cytokines and nitric oxide metabolites in neuropsychiatric lupus erythematosus. Ann Rheum Dis (2001) 1.16
Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis. Scand J Immunol (2002) 1.14
Expression of MHC class I heavy chain and beta2-microglobulin in rat brainstem motoneurons and nigral dopaminergic neurons. J Neuroimmunol (1999) 1.14
Environmental influences on psychological restoration. Scand J Psychol (1996) 1.13
Interferon gamma, interleukin 4 and transforming growth factor beta in experimental autoimmune encephalomyelitis in Lewis rats: dynamics of cellular mRNA expression in the central nervous system and lymphoid cells. J Neurosci Res (1995) 1.13
Improved detection of oligoclonal IgG in cerebrospinal fluid by isoelectric focusing in agarose, double-antibody peroxidase labeling, and avidin-biotin amplification. Clin Chem (1984) 1.12
Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J Clin Invest (1991) 1.10
Frequency of edentulism and identification marking of removable dentures in long-term care units. J Oral Rehabil (1996) 1.09
Some pharmacological properties of terbutaline (INN), 1-(3,5-dihydroxyphenyl)-2-(T-butylamino)-ethanol. A new sympathomimetic beta-receptor-stimulating agent. Acta Med Scand Suppl (1970) 1.08
Insulin secretion and incretin hormones after oral glucose in non-obese subjects with impaired glucose tolerance. Metabolism (2004) 1.07
Sunlight is associated with decreased multiple sclerosis risk: no interaction with human leukocyte antigen-DRB1*15. Eur J Neurol (2012) 1.07
Detection of C polysaccharide in Streptococcus pneumoniae in the sputa of pneumonia patients by an enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 1.07
Myelin antigen reactive T cells in cerebrovascular diseases. Clin Exp Immunol (1992) 1.07
Increased IL-10 mRNA and IL-23 mRNA expression in multiple sclerosis: interferon-beta treatment increases IL-10 mRNA expression while reducing IL-23 mRNA expression. Mult Scler (2008) 1.06
Glucocorticoids, hippocampal corticosteroid receptor gene expression and antidepressant treatment: relationship with spatial learning in young and aged rats. Neuroscience (1995) 1.06
The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment-sensitive biomarkers. Eur J Neurol (2009) 1.05
Assessment of renal parenchymal thickness in normal children. Acta Radiol Diagn (Stockh) (1981) 1.05
A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS. Neurology (2011) 1.05
Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human HIV infection. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.05
Swedish natalizumab (Tysabri) multiple sclerosis surveillance study. Neurol Sci (2011) 1.05
A Trypanosoma brucei brucei-derived factor that triggers CD8+ lymphocytes to interferon-gamma secretion: purification, characterization and protective effects in vivo by treatment with a monoclonal antibody against the factor. Scand J Immunol (1993) 1.04
Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis. Mult Scler (2011) 1.04
Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort. Stroke (1999) 1.03
Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA. J Neuroimmunol (2000) 1.03
The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J Neuroimmunol (2001) 1.03
Memantine abrogates neurological deficits, but not CNS inflammation, in Lewis rat experimental autoimmune encephalomyelitis. J Neurol Sci (1996) 1.01
Environmental influences on the central nervous system and their implications for the aging rat. Behav Brain Res (1993) 1.01
Distribution of a calcium channel subunit in dystrophic axons in multiple sclerosis and experimental autoimmune encephalomyelitis. Brain (2001) 1.00
Development of visual and somatosensory evoked responses in pre-term newborn infants. Electroencephalogr Clin Neurophysiol (1973) 1.00
Plasma CD93 concentration is a potential novel biomarker for coronary artery disease. J Intern Med (2011) 1.00
Cerebrospinal fluid immunoglobulin abnormalities in systemic lupus erythematosus. J Neurol Neurosurg Psychiatry (1985) 1.00
The gene for a T lymphocyte triggering factor from African trypanosomes. J Exp Med (1997) 0.99
Analysis of cerebrospinal fluid and cerebrospinal fluid cells from patients with multiple sclerosis for detection of JC virus DNA. Mult Scler (2008) 0.99
Expression of nonclassical MHC class I (RT1-U) in certain neuronal populations of the central nervous system. Eur J Neurosci (1999) 0.99
In situ hybridization analysis of synovial and systemic cytokine messenger RNA expression in superantigen-mediated Staphylococcus aureus arthritis. Arthritis Rheum (1996) 0.98
Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis. J Exp Med (1998) 0.98
Axotomy induces MHC class I antigen expression on rat nerve cells. Neurosci Lett (1988) 0.98
T cell immunity and interferon-gamma secretion during experimental allergic encephalomyelitis in Lewis rats. J Neuroimmunol (1991) 0.97
Low and high circulating cortisol levels predict mortality and cognitive dysfunction early after stroke. J Intern Med (2004) 0.97
Local enhancement of major histocompatibility complex (MHC) class I and II expression and cell infiltration in experimental allergic encephalomyelitis around axotomized motor neurons. J Neuroimmunol (1989) 0.97
Human and rodent interferon-gamma as a growth factor for Trypanosoma brucei. Eur J Immunol (1996) 0.97
Glucocorticoid hypersecretion and the age-impaired hippocampus: cause or effect? J Endocrinol (1995) 0.97
A Palaeolithic-type diet causes strong tissue-specific effects on ectopic fat deposition in obese postmenopausal women. J Intern Med (2013) 0.96
Cognitive impairment in young adults with infratentorial infarcts. Neurology (1998) 0.96
Antibodies to myelin-associated glycoprotein are found in cerebrospinal fluid in polyneuropathy associated with monoclonal serum IgM. Arch Neurol (1991) 0.96
Interrelationships between plasma testosterone, SHBG, IGF-I, insulin and leptin in prostate cancer cases and controls. Eur J Cancer Prev (2003) 0.95